Vertex Pharmaceuticals Incorporated

Financials

Activos totales 11.75 B13.43 B18.15 B22.73 B22.53 B25.64 B Total de pasivos 3.06 B3.33 B4.24 B5.15 B6.12 B6.98 B Capital total 8.69 B10.1 B13.91 B17.58 B16.41 B18.67 B Total de pasivos y patrimonio neto 11.75 B13.43 B18.15 B22.73 B22.53 B25.64 B Deuda total —————— Deuda neta ——————

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

VRTX

Financials

Vertex Pharmaceuticals Incorporated

Noticias

Argenx y Vertex Pharmaceuticals, principales apuestas de BofA en biotecnología para 2026

Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

What to Expect From Vertex Pharmaceuticals’ Q1 2026 Earnings Report

Undercovered Dozen: CVR Energy, Greystone Housing, Conagra Brands, And More

Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Halozyme licencia tecnología Hypercon a Vertex por 15 millones de dólares

Leerink reitera calificación de Halozyme tras acuerdo con Vertex

William Blair reitera calificación de acciones de Amgen tras datos positivos de Tepezza

Vertex Pharmaceuticals: Label Expansions For ALYFTREK & TRIKAFTA Plus Strong Demand (VRTX)

RBC Capital reitera calificación de Amgen por crecimiento diversificado